revenue $278.6M, net income $5.2M. IPG revenue +11.1% as operating income surges, but net income falls on tax drag

Filed August 4, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 5, 2025 · ~2 min read

Key Changes

• high

  Operating income jumped 4257% YoY to $4.5M, but net income fell 20.6% to $5.2M — the divergence driven by a $5.8M below-the-line drag (non-operating/other -$157K, income tax -$5.6M). The net-income decline did not come from operations.

  MD&A: Operating Results verify on EDGAR →
• high

  Announced put option to acquire Lumibird Medical for €300M cash plus up to €50M earn-out (2026-2027 targets). Closing expected Q4 2026, subject to French works council consultation and foreign investment approval.

  Subsequent Events verify on EDGAR →
• high

  Settled Trumpf patent litigation for $13.5M, covering past damages on adjustable mode beam lasers. Ongoing royalty charges will hit cost of sales. Separately, recorded $17.6M impairment to sell Belarus operations (primarily currency translation adjustments).

  MD&A: Litigation Settlement & Belarus Disposal verify on EDGAR →